Physician profile
Hammad Mohammad Zafar
NPI 1164809711
$13,271.01
in general payments reported to CMS, 2019-2025
53 companies · $1,196 in 2025
The $1,196 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $7,477 · 2020: $325 · 2021: $1,592 · 2022: $726 · 2023: $486 · 2024: $1,469 · 2025: $1,196.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,151.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $5,467.79 | 2019 | |
| Stryker Corporation | $1,845.74 | 2019-2025 | Hoffmann, Ortholoc 3di Crosscheck, Salvation |
| Wright Medical Technology, INC. | $1,059.30 | 2019-2020 | |
| Paragon 28, INC. | $980.10 | 2021 | |
| Abbvie INC. | $897.89 | 2021-2025 | Dalvance |
| Paratek Pharmaceuticals, INC. | $247.00 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $224.36 | 2022-2025 | Puraply, Puraply Wound Matrix |
| Integra Lifesciences Corporation | $208.73 | 2019-2021 | |
| Abbott Laboratories | $175.67 | 2021-2023 | Eterna |
| Djo, LLC | $145.22 | 2021-2025 | Cmf |
| Celgene Corporation | $125.45 | 2024-2025 | Reblozyl |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $124.99 | 2024 | Xifaxan |
| Advanced Oxygen Therapy INC. | $121.77 | 2024-2025 | Topical Oxygen Chamber For Extremities |
| Smith+Nephew, INC. | $110.50 | 2020-2024 | Evos, Panta 2, Pico 7 |
| Orthofix Medical, INC. | $92.92 | 2020-2025 | Physio-Stim |
Show all 53 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $89.71 | 2021-2025 | Motoband |
| Horizon Therapeutics Plc | $80.20 | 2021-2023 | Krystexxa |
| Medtronic, INC. | $79.25 | 2022-2024 | Intellis Adaptivestim |
| Arteriocyte Medical Systems, INC. | $77.14 | 2022-2024 | Magellan |
| Mimedx Group, INC. | $76.85 | 2024-2025 | |
| Kci USA, INC. | $76.02 | 2020-2022 | |
| Fusion Orthopedics USA, LLC | $74.68 | 2025 | |
| Musculoskeletal Transplant Foundation INC. | $58.10 | 2023-2025 | |
| Osteomed LLC | $56.80 | 2020-2021 | |
| Bard Peripheral Vascular, INC. | $47.15 | 2019 | |
| Bioventus LLC | $46.08 | 2022 | |
| Alfasigma USA, INC. | $45.89 | 2021-2022 | |
| Acell, INC. | $44.47 | 2019 | |
| Treace Medical Concepts, INC. | $39.01 | 2022 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $38.47 | 2022-2024 | Jublia |
| Xtant Medical INC | $37.07 | 2024 | |
| Amgen INC. | $35.46 | 2024-2025 | Krystexxa |
| Aap Implants INC | $31.66 | 2022 | |
| Convatec INC. | $30.74 | 2024 | |
| Osteocentric Technologies, INC. | $30.17 | 2022-2024 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
| Kerecis Limited | $29.35 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Triad Life Sciences INC. | $28.39 | 2022 | |
| Daiichi Sankyo INC. | $25.73 | 2024 | Enhertu |
| Globus Medical, INC. | $22.22 | 2022 | |
| Solventum Corporation | $21.78 | 2024 | V.A.C.Instill, Activ.A.C., Prevena |
| Reprise Biomedical, INC. | $21.31 | 2025 | Miro3d |
| Zimmer Biomet Holdings, INC. | $20.63 | 2022 | |
| Biowound Solutions, INC. | $20.16 | 2024 | Bio-Connekt |
| Misonix INC | $19.73 | 2021 | |
| Innovation Technologies INC | $19.51 | 2024 | Irrisept |
| Orpyx Medical Technologies US INC. | $18.98 | 2023 | Orpyx Si |
| Hartmann USA, INC. | $18.05 | 2024 | Zetuvit Plus 10x10 P10 |
| Lifenet Health | $17.57 | 2025 | Theragenesis Wound Matrix |
| Electronic Waveform Lab, INC. | $16.23 | 2024 | |
| Nevro Corp. | $15.37 | 2024 | Senza |
| Baudax Bio INC. | $12.43 | 2021 | |
| Stimwave Technologies Incorporated | $12.14 | 2020 | |
| Flower Orthopedics Coporation | $9.08 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hammad Zafar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.